F15.280
Other stimulant dependence with stimulant-induced anxiety disorder
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code F15.280 refers to a condition characterized by dependence on stimulants accompanied by stimulant-induced anxiety disorder. This health issue involves a compulsive need to use stimulant substances, such as amphetamines or cocaine, resulting in significant health and psychological challenges. The disorder not only includes dependence but also the development of anxiety symptoms directly triggered by stimulant use, affecting an individual's well-being and daily functioning.
Causes & Symptoms
Clinical Causes: Prolonged or heavy use of stimulant substances like cocaine, amphetamines, or similar drugs. Genetic predisposition to substance dependence and anxiety disorders. Environmental factors such as peer pressure, stress, or traumatic experiences that promote stimulant use. Underlying mental health conditions that increase vulnerability to substance dependence. Repeated exposure to stimulants leading to neurochemical changes in the brain, reinforcing dependence.
Key Symptoms: Craving or compulsive desire to use stimulants. Feeling unable to stop using despite negative consequences. Development of anxiety symptoms such as restlessness, nervousness, or panic attacks. Physical signs like increased heart rate, sweating, tremors, or insomnia. Difficulty concentrating or experiencing rapid mood swings. Social withdrawal or neglect of personal responsibilities due to substance use. Possible paranoia or hallucinations during or after stimulant effects.
Diagnostic & Treatment
Diagnosis Path: Detailed patient history focusing on substance use and mental health symptoms. Physical examination to identify signs of stimulant use or dependence. Psychological evaluation to assess anxiety symptoms and their relationship to stimulant use. Laboratory tests, such as blood or urine screens, to detect recent stimulant consumption. Application of diagnostic criteria from mental health classification systems to confirm dependence and induced anxiety disorder.
Treatment Protocols: Behavioral therapies like cognitive-behavioral therapy (CBT) aimed at modifying substance use behaviors and managing anxiety symptoms. Detoxification programs to safely manage withdrawal symptoms. Medication-assisted treatment to reduce cravings or address anxiety, prescribed by healthcare providers. Support groups and counseling to provide ongoing emotional support and relapse prevention. Addressing co-occurring mental health conditions through psychiatric evaluation and therapy. Lifestyle modifications including stress management techniques, healthy routines, and social support.
Clinical Advice & FAQs
Billing Guidance
Is F15.280 a billable ICD-10 code?
Yes, F15.280 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F15.280?
Clinical documentation must specify the nature of Other stimulant dependence with stimulant-induced anxiety disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference